UK MHRA relocates, parting with the Device Evaluation Service:
This article was originally published in Clinica
The medical devices unit of the UK Medicines and Healthcare products Regulatory Agency is relocating at the end of this week from its Hannibal House address in Southeast London to the agency's head office (Market Towers, 1 Nine Elms Lane, London SW8 5NQ). It leaves behind, however, the Device Evaluation Service that it operates, in a move that is, at the very least, symbolic of the DES' prospective shift towards the procurement arena, and away from the regulatory (see Clinica No 1134, p 6). See: http://devices.mhra.gov.uk/
You may also be interested in...
GSK creates another partnership centered on its vaccine adjuvant technology, this time with China's Xiamen Innovax.
Lab testing for COVID-19 has risen to a new high of 314,000 tests per week in Germany, where the concerns are perhaps less about test availability than staff numbers to oversee the testing protocols.
A new European Commission guidance document explains the regulatory basics and much- altered emergency market entry criteria for new entrants to devices sector amid the COVID-19 crisis.